36 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:19pm
in additional sanctions or other international action, any of which may have a destabilizing effect on supply chain disruptions which may adversely
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
of prescription pharmaceutical product samples and impose requirements to ensure accountability in distribution. Most recently, the Drug Supply Chain Security
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
by the international community and may result in additional sanctions or other international action, any of which may have a destabilizing effect on supply chain disruptions
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:12pm
result in additional sanctions or other international action, any of which may have a destabilizing effect on supply chain disruptions which may adversely
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
the distribution of prescription pharmaceutical product samples and impose requirements to ensure accountability in distribution. Most recently, the Drug Supply … Chain Security Act (“DSCSA”) was enacted with the aim of building an electronic system to identify and trace certain prescription drugs distributed
424B3
q7jb5zhbt94u0yqym
13 Jun 24
Prospectus supplement
4:10pm
6-K
EX-99.2
7ac4zrukt9 hbww2v9n
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
424B5
tfcvwr56o3hnbk
29 Nov 23
Prospectus supplement for primary offering
9:57pm
6-K
EX-99.2
xmmmv5v7m0rjcdcer
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
424B3
hdcd od3iv5hi0p9g9vt
25 Aug 23
Prospectus supplement
6:00am
424B3
wl4 d0dd8mpz
25 Aug 23
Prospectus supplement
6:00am
6-K
EX-99.2
hcd irm6i
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am
6-K
EX-99.2
kcrpey2d 4g
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am
6-K
EX-99.3
4lp qscq3sy
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.2
37nwzngpqm342af8kqdg
3 Apr 23
Consolidated Financial Statements
6:05am
424B3
5geo5 9z11v2jcg8q0b4
14 Nov 22
Prospectus supplement
1:51pm